These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 37765177)

  • 1. Imidazoles as Serotonin Receptor Modulators for Treatment of Depression: Structural Insights and Structure-Activity Relationship Studies.
    Goel KK; Thapliyal S; Kharb R; Joshi G; Negi A; Kumar B
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy.
    Kumar U; Medel-Matus JS; Redwine HM; Shin D; Hensler JG; Sankar R; Mazarati A
    Epilepsia; 2016 Mar; 57(3):506-15. PubMed ID: 26813337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs.
    Mandrioli R; Protti M; Mercolini L
    Curr Med Chem; 2018; 25(7):772-792. PubMed ID: 28707591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
    Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M
    Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective serotonin reuptake inhibitors and newer antidepressive substances in child and adolescent psychiatry].
    Heiser P; Remschmidt H
    Z Kinder Jugendpsychiatr Psychother; 2002 Aug; 30(3):173-83. PubMed ID: 12227220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats.
    Ulak G; Mutlu O; Akar FY; Komsuoğlu FI; Tanyeri P; Erden BF
    Pharmacol Biochem Behav; 2008 Oct; 90(4):563-8. PubMed ID: 18565575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between warfarin combined with serotonin-modulating antidepressants and increased case fatality in primary intracerebral hemorrhage: a population-based study.
    Löppönen P; Tetri S; Juvela S; Huhtakangas J; Saloheimo P; Bode MK; Hillbom M
    J Neurosurg; 2014 Jun; 120(6):1358-63. PubMed ID: 24506245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of patients with major depressive disorder switching SSRI/SNRI therapy compared with those augmenting with an atypical antipsychotic in a real-world setting.
    Kern DM; Cepeda MS; Castilla-Puentes RC; Savitz A; Etropolski M
    Curr Med Res Opin; 2021 Aug; 37(8):1377-1384. PubMed ID: 33818238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant Drugs Effects on Blood Pressure.
    Calvi A; Fischetti I; Verzicco I; Belvederi Murri M; Zanetidou S; Volpi R; Coghi P; Tedeschi S; Amore M; Cabassi A
    Front Cardiovasc Med; 2021; 8():704281. PubMed ID: 34414219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
    Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
    CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different depression: motivational anhedonia governs antidepressant efficacy in Huntington's disease.
    McLauchlan DJ; Lancaster T; Craufurd D; Linden DEJ; Rosser AE
    Brain Commun; 2022; 4(6):fcac278. PubMed ID: 36440100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors Are Not Associated With Bleeding or Transfusion in Cardiac Surgical Patients.
    Smith MM; Smith BB; Lahr BD; Nuttall GA; Mauermann WJ; Weister TJ; Dearani JA; Barbara DW
    Anesth Analg; 2018 Jun; 126(6):1859-1866. PubMed ID: 29210786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Recurrent Falls and Medication Use during Acute-Care Hospitalization: A Retrospective Descriptive Study.
    Hirai T; Ishikawa Y; Kawagoe Y; Ogawa Y; Ogawa R; Itoh T
    Biol Pharm Bull; 2019; 42(7):1192-1198. PubMed ID: 31257294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and Antidepressants: A Comprehensive Review and Clinical Outlook of the Risks and Benefits of Co-prescription (2022).
    Gutlapalli SD; Chaudhuri D; Khan KI; Al Shouli R; Allakky A; Ferguson AA; Khan AI; Abuzainah B; Mohammed L
    Cureus; 2022 Dec; 14(12):e32331. PubMed ID: 36632257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacological basis of the serotonin system: Application to antidepressant response].
    David DJ; Gardier AM
    Encephale; 2016 Jun; 42(3):255-63. PubMed ID: 27112704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New perspectives in the serotoninergic treatment for depression].
    Hamon M
    Therapie; 1995; 50(6):505-9. PubMed ID: 8745948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.